Article
Personalised medicine in asthma: time for action: Number 1 in the Series "Personalised medicine in respiratory diseases" Edited by Renaud Louis and Nicolas Roche.
European respiratory review : an official journal of the European Respiratory Society - 30 Sept 2017
Chung Kian Fan
Abstract excerpt
Asthma is a heterogeneous disease comprising several phenotypes driven by different pathways. To define these phenotypes or endotypes (phenotypes defined by mechanisms), an unbiased approach to clustering of various omics platforms will yield molecular phenotypes from which composite biomarkers can be obtained. Biomarkers can help differentiate between these phenotypes and pinpoint patients suitable for specific...
Topics
- Anti-Asthmatic Agents
- Asthma
- Clinical Decision-Making
- Genetic Predisposition to Disease
- Humans
- Lung
- Molecular Diagnostic Techniques
- Patient Selection
- Phenotype
- Precision Medicine
- Predictive Value of Tests
- Risk Factors
- Telemedicine